Liquid Biopsy Market Share

  • Report ID: 69
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Global Liquid Biopsy Market TOC

  1. Market Definition
    1. Market Definition
    2. Market Segmentation
    3. Product Overview
  2. Research Methodology
    1. Research Process
    2. Primary Research
      1. Manufacturers
      2. End-users
    3. Secondary research
    4. Market size estimation
  3. Executive Summary- Global Liquid Biopsy Market
  4. Analysis of Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  5. Regulatory & Standards Landscape
  6. Pricing Analysis
  7. Epidemiology Analysis
  8. Impact of COVID-19 on the Liquid Biopsy Market
    1. Pre-COVID-19 Scenario, 2017-19
    2. COVID-19 scenario, 2020
    3. Post-COVID-19 scenario
  9. Comparative Analysis (Liquid biopsy vs Tissue-based biopsy)
  10. End-User Usability Analysis
  11. Competitive Structure
  12. Global Liquid Biopsy Market Outlook
    1. Global Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
        1.                           Tools, 2019-2028F (USD Million)
          1. Next generation sequencing (NGS), 2019-2028F (USD Million)
          2. Polymerase chain reaction (PCR), 2019-2028F (USD Million)
          3. Microarrays, 2019-2028F (USD Million)
        2. Assay kits & reagents, 2019-2028F (USD Million)
        3. Services, 2019-2028F (USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
        1. Circulating Tumor Cells, 2019-2028F (USD Million)
        2. Circulating Tumor DNA, 2019-2028F (USD Million)
        3. Exosomes, 2019-2028F (USD Million)
        4. Circulating RNA & Proteins, 2019-2028F (USD Million)
        5. Nucleosomes, 2019-2028F (USD Million)
      3. By Sample, 2019-2028F (in USD Million)
        1. Blood, 2019-2028F (USD Million)
        2. Urine, 2019-2028F (USD Million)
        3. Others, 2019-2028F (USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
        1. Early Disease Screening, 2019-2028F (USD Million)
        2. Therapy Selection, 2019-2028F (USD Million)
        3. Treatment Response Monitoring, 2019-2028F (USD Million)
        4. Molecular Health Monitoring, 2019-2028F (USD Million)
        5. Others, 2019-2028F (USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
        1. Lung Cancer, 2019-2028F (USD Million)
        2. Colorectal Cancer, 2019-2028F (USD Million)
        3. Breast Cancer, 2019-2028F (USD Million)
        4. Prostate Cancer, 2019-2028F (USD Million)
        5. Liver Cancer, 2019-2028F (USD Million)
        6. Head & Neck Cancer, 2019-2028F (USD Million)
        7. Others, 2019-2028F (USD Million)
      6. By End-User, 2019-2028F (in USD Million)
        1. Hospitals, 2019-2028F (USD Million)
        2. Clinics, 2019-2028F (USD Million)
        3. Research Laboratories, 2019-2028F (USD Million)
        4. Academic Institutes, 2019-2028F (USD Million)
        5. Others, 2019-2028F (USD Million)
      7. By Region, 2019-2028F (in USD Million)
        1. North America, 2019-2028F (in USD Million)
        2. Europe, 2019-2028F (in USD Million)
        3. Asia Pacific, 2019-2028F (in USD Million)
        4. Latin America, 2019-2028F (in USD Million)
        5. Middle East & Africa, 2019-2028F (in USD Million)
  13. North America Liquid Biopsy Market Outlook
    1. North America Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  14. Latin America Liquid Biopsy Market Outlook
    1. Latin America Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  15. Europe Liquid Biopsy Market Outlook
    1. Europe Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  16. Asia Pacific Liquid Biopsy Market Outlook
    1. Asia Pacific Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  17. Middle East & Africa Liquid Biopsy Market Outlook
    1. Middle East & Africa Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  18. Competitive Structure
    1. Qiagen
    2. F. Hoffmann-La Roche Ltd
    3. Bio-Rad Laboratories, Inc.
    4. Illumina, Inc.
    5. Inivata Limited
    6. Agena Bioscience, Inc.
    7. Thermo Fisher Scientific
    8. Guardant Health, Inc.

Liquid Biopsy Market Share

Regionally, the global market is segmented into five major regions, which include North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America industry is expected to hold largest revenue share of 36% by 2036. The market in the region is further expected to grow at a CAGR of 29.7% during the forecast period. On the other hand, the Europe liquid biopsy market is projected to hold second leading stance by garnering a revenue of USD 1228.8 Million in 2021. The growth of the market in the region can be attributed to the rising healthcare expenditure in the major countries of Europe, such as Germany, UK, Spain, and Russia.

Furthermore, in the North American region, the United States is projected to generate significant growth opportunities for market growth by attaining a revenue of 1284.3 USD Million in 2021, while Canada is projected to reap 154.4 USD Million in revenue during the same year. The North American market presently captures the larger share due to the region's robust healthcare infrastructure. Additionally, the growing prevalence of cancer in the region is also expected to generate massive demand for liquid biopsy over the forecast period. Moreover, the increasing initiatives by the U.S. government to upgrade the facilities in cancer care is also expected to favor the market's growth in the coming years. Furthermore, improved research infrastructure and increasing investments in R&D in the healthcare industry alongside the initiatives taken by the U.S. government are some of the other factors expected to contribute to the growth of the market. Over the years, government spending on healthcare resources has significantly increased the regulatory landscape, which is also a prominent factor driving the market's growth.

Research Nester
Global-Liquid-Biopsy-Market-Value-By-Disease-Indication
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 69
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing incidence of cancer and, rising research and development activities are the major factors responsible for the growth of the market.

The market is anticipated to attain a CAGR of 30.7% over the forecast period i.e., 2020-2028.

High regulatory standards associated with biopsy procedures is estimated to act as barriers to the market growth.

Asia Pacific is estimated to create notable growth opportunities for market growth over the forecast period.

The major players in the market are Qiagen, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Illumina, Inc., Inivata Limited, Agena Bioscience, Inc., Thermo Fisher Scientific, Guardant Health, Inc. and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample